Director of Research
In the Ley Group, we specialise in developing new synthesis methods and applying them to the construction of biologically important molecules. Over the years we have completed the total synthesis of many natural products, including: spongistatin 1 (anti-mitotic agent); rapamycin (immunosuppressant); thapsigargin (SERCA pumps inhibitor); azadirachtin (insect antifeedant); and bengazole A (fungicide). In addition to our research on natural product synthesis, we also pioneered flow chemistry and machine assisted synthesis.
For more detailed research information and our publication list, please see our legacy group website.
Completed Natural Products

Publications
An electrophysiological and behavioural study of insect antifeedant properties of natural and synthetic drimane-related compounds.
Physiological entomology.
(2008)
12
281
Azide monoliths as convenient flow reactors for efficient Curtius rearrangement reactions.
Organic and Biomolecular Chemistry
(2008)
6
1587
(doi: 10.1039/b801634h)
A modular flow reactor for performing Curtius rearrangements as a continuous flow process
Organic & biomolecular chemistry
(2008)
6
1577
(doi: 10.1039/b801631n)
Facile, one-step production of niacin (vitamin B3) and other nitrogen-containing pharmaceutical chemicals with a single-site heterogeneous catalyst
Chemistry A European Journal
(2008)
14
2340
(doi: 10.1002/chem.200701679)
Functionalised butanediacetal-protected 1,2-diols as suitable partners for Pd-catalysed cross-coupling reactions
Tetrahedron
(2008)
64
2348
(doi: 10.1016/j.tet.2008.01.010)
Azeotropic reflux chromatography : an efficient solution to a difficult separation in the scale-up synthesis of spongistatin 1
Organic & biomolecular chemistry
(2008)
6
1159
(doi: 10.1039/b719569a)
Synthesis of Natural Products from the Indian Neem TreeAzadirachta indica
Organic letters
(2008)
10
569
(doi: 10.1021/ol7027898)
Microreactors in organic synthesis and catalysis
(2008)
Total synthesis studies on macrocyclic pipecolic acid natural products: FK506, the antascomicins and rapamycin.
Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques
(2008)
66
13
(doi: 10.1007/978-3-7643-8595-8_2)
- ‹ previous
- Page 36